Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona

Protein corona of nanoparticles (NPs), which forms when these particles come in to contact with protein-containing fluids, is considered as an overlooked factor in nanomedicine. Through numerous studies it has been becoming increasingly evident that it importantly dictates the interaction of NPs with their surroundings. Several factors that determine the compositions of NPs protein corona have been identified in recent years, but one has remained largely ignored—the composition of media used for dispersion of NPs. Here, we determined the effect of dispersion media on the composition of protein corona of polyacrylic acid-coated cobalt ferrite NPs (PAA NPs) and silica NPs. Our results confirmed some of the basic premises such as NPs type-dependent specificity of the protein corona. But more importantly, we demonstrated the effect of the dispersion media on the protein corona composition. The differences between constituents of the media used for dispersion of NPs, such as divalent ions and macromolecules were responsible for the differences in protein corona composition formed in the presence of fetal bovine serum (FBS). Our results suggest that the protein corona composition is a complex function of the constituents present in the media used for dispersion of NPs. Regardless of the dispersion media and FBS concentration, majority of proteins from either PAA NPs or silica NPs coronas were involved in the process of transport and hemostasis. Interestingly, corona of silica NPs contained three complement system related proteins: complement factor H, complement C3 and complement C4 while PAA NPs bound only one immune system related protein, α-2-glycoprotein. Importantly, relative abundance of complement C3 protein in corona of silica NPs was increased when NPs were dispersed in NaCl, which further implies the relevance of dispersion media used to prepare NPs.

[1]  Robert B Sim,et al.  The Complement System in Innate Immunity , 2008 .

[2]  Xianghui Xu,et al.  A magnetic-dependent protein corona of tailor-made superparamagnetic iron oxides alters their biological behaviors. , 2016, Nanoscale.

[3]  F. Tourinho,et al.  Aqueous ferrofluids based on manganese and cobalt ferrites , 1990 .

[4]  Conrad Coester,et al.  Particle and Fibre Toxicology BioMed Central Methodology , 2008 .

[5]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[6]  M. Mahmoudi,et al.  Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. , 2015, Nanoscale.

[7]  Hanfa Zou,et al.  Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles. , 2014, Colloids and surfaces. B, Biointerfaces.

[8]  Alaaldin M. Alkilany,et al.  Protein corona: Opportunities and challenges. , 2016, The international journal of biochemistry & cell biology.

[9]  V. Bregar,et al.  STABILITY OF NANOPARTICLE SUSPENSIONS IN DIFFERENT BIOLOGICALLY RELEVANT MEDIA , 2012 .

[10]  Marilena Hadjidemetriou,et al.  Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles. , 2016, Nanoscale.

[11]  Sílvia A. Ferreira,et al.  IgG and fibrinogen driven nanoparticle aggregation , 2015, Nano Research.

[12]  D. Drobne,et al.  Comparative study of serum protein binding to three different carbon-based nanomaterials , 2015 .

[13]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[14]  Andrew Emili,et al.  Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.

[15]  Bengt-Harald Jonsson,et al.  Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[16]  Morteza Mahmoudi,et al.  Personalized protein coronas: a "key" factor at the nanobiointerface. , 2014, Biomaterials science.

[17]  Katharina Landfester,et al.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.

[18]  L. Tauzin,et al.  Adsorption and Unfolding of a Single Protein Triggers Nanoparticle Aggregation , 2016, ACS nano.

[19]  K. Landfester,et al.  Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. , 2016, Nanoscale.

[20]  Raimo Hartmann,et al.  Temperature: the "ignored" factor at the NanoBio interface. , 2013, ACS nano.

[21]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[22]  Erno Pungor,et al.  Proteomic Analysis for the Assessment of Different Lots of Fetal Bovine Serum as a Raw Material for Cell Culture. Part IV. Application of Proteomics to the Manufacture of Biological Drugs , 2008, Biotechnology progress.

[23]  M. Toprak,et al.  Keeping it real: The importance of material characterization in nanotoxicology. , 2015, Biochemical and biophysical research communications.

[24]  Raehyun Kim,et al.  The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum. , 2016, The international journal of biochemistry & cell biology.

[25]  Darren J. Martin,et al.  Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.

[26]  Stefan Tenzer,et al.  Quantitative profiling of the protein coronas that form around nanoparticles , 2014, Nature Protocols.

[27]  A. Johansson,et al.  Quantitation of protein adsorbance to glass and plastics: investigation of a new tube with low adherence. , 1978, Journal of immunological methods.

[28]  Y. Barenholz Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[29]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[30]  G. Caracciolo,et al.  The protein corona of circulating PEGylated liposomes. , 2016, Biochimica et biophysica acta.

[31]  Iseult Lynch,et al.  Serum heat inactivation affects protein corona composition and nanoparticle uptake. , 2010, Biomaterials.

[32]  Katharina Landfester,et al.  Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. , 2011, ACS nano.

[33]  Jackie Y Ying,et al.  Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. , 2005, Journal of the American Chemical Society.

[34]  Jing Wang,et al.  Mesoporous Silica‐Coated Gold Nanorods as a Light‐Mediated Multifunctional Theranostic Platform for Cancer Treatment , 2012, Advanced materials.

[35]  S. Pirkmajer,et al.  Cell type-specific response to high intracellular loading of polyacrylic acid-coated magnetic nanoparticles , 2015, International journal of nanomedicine.

[36]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[37]  Stefan Tenzer,et al.  Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.

[38]  Michael Maskos,et al.  Protein corona – from molecular adsorption to physiological complexity , 2015, Beilstein journal of nanotechnology.

[39]  E. Gazzano,et al.  Fibrinogen enhances the inflammatory response of alveolar macrophages to TiO2, SiO2 and carbon nanomaterials , 2014, Nanotoxicology.

[40]  R. Zhou,et al.  Binding of blood proteins to carbon nanotubes reduces cytotoxicity , 2011, Proceedings of the National Academy of Sciences.

[41]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[42]  S. Moghimi,et al.  Just so stories: the random acts of anti-cancer nanomedicine performance. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[43]  M. Mahmoudi,et al.  Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. , 2016, Biomaterials.

[44]  Bengt Fadeel,et al.  Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages , 2015, PloS one.

[45]  Jens M. Rick,et al.  Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.

[46]  J. Mihály,et al.  Enhanced stability of polyacrylate-coated magnetite nanoparticles in biorelevant media. , 2012, Colloids and surfaces. B, Biointerfaces.

[47]  Roberto Cingolani,et al.  Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.

[48]  Istvan Toth,et al.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.

[49]  G. Caracciolo,et al.  Stealth effect of biomolecular corona on nanoparticle uptake by immune cells. , 2015, Langmuir : the ACS journal of surfaces and colloids.

[50]  R. Stöcklin,et al.  Conus consors snail venom proteomics proposes functions, pathways, and novel families involved in its venomic system. , 2012, Journal of proteome research.

[51]  F. Schacher,et al.  Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction. , 2016, The international journal of biochemistry & cell biology.

[52]  Mojca Pavlin,et al.  Visualization of internalization of functionalized cobalt ferrite nanoparticles and their intracellular fate , 2013, International journal of nanomedicine.

[53]  Eleonore Fröhlich,et al.  The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles , 2012, International journal of nanomedicine.